Botanical Solution, Inc. Secures Additional $7 Million, Totaling Over $13 Million In Series A Funding

Aug 24, 2023•over 2 years ago

Amount Raised

$7 Million

Round Type

series a

DavisBiotechnology

Investors

Quebec LpBoldo Sp AOtter Capital

Description

Botanical Solution Inc. (BSI), the multiple award-winning innovator of sustainable, highly consistent and cost effective Advanced Botanical Materials, has successfully secured an additional $7 million investment.

Company Information

Company

Botanical Solutions

Location

Davis, California, United States

About

Botanical Solution Inc., a Delaware Corporation, has a proprietary platform for sustainable and improved production of consistent, high quality Advanced Botanical Materials (ABM). ABM-01 is the first ABM produced by the company, based on a plant called Quillaja saponaria. ABM-01 is the active ingredient used in two gold standard products, BSI’s biopesticide Quillibrium® and the vaccine adjuvant QS-21, used in a Shingles blockbuster vaccine, a recently launched RSV vaccine and a Malaria vaccine. The Company has received a widespread industry recognition for innovation, winning the “2023 Best Process Innovation Award” from ICIS Chemical Business, the 2022 “New Biotech Business of the Year Award” from BioProtection Forum and the “2022 Product of the Year Award” from S&P Crop Science. To learn more visit us at www.botanical-solution.com/news

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns